Author

B. A. Hanks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Holtzhausen· 1 shared A. V. DiMarco· 1 shared B. McKinney· 1 shared B. Theivanthiran· 1 shared G. Beasley· 1 shared J. Force· 1 shared J. V. Alvarez· 1 shared J. Xie· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Holtzhausen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintApr 26, 2023

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

M. P. Plebanek, Y. Xue, Y.-V. Nguyen…·B. A. Hanks

The paper identifies SREBF2 as a regulator of mregDC development and function in the tumor microenvironment, highlighting it as a therapeutic target for immune tolerance.

DOI 10.1101/2023.04.26.538456

humanbulk RNA-seq

Cancer BiologybioRxivFeb 13, 2021

APOBEC mutagenesis inhibits breast cancer growth through induction of a T cell-mediated antitumor immune response

A. V. DiMarco, X. Qin, S. Van Alsten…·J. V. Alvarez

This study shows that APOBEC mutagenesis in breast cancer promotes T cell-mediated antitumor immunity, leading to tumor growth inhibition and sensitivity to checkpoint inhibitors.

DOI 10.1158/2326-6066.cir-21-0146

mouseexperimental assay